Herpes Zoster Risk in Rheumatoid Arthritis Patients on Janus Kinase Inhibitors: A 17-Year Experience from Rheumatoid Arthritis Saudi Database (RASD)
{{output}}
Background/purpose: The advent of targeted therapies, such as biologic disease-modifying anti-rheumatic drugs (bDMARDs) and Janus kinase inhibitors (JAKi), has revolutionized the treatment of rheumatoid arthritis (RA) patients wh... ...
